Literature DB >> 12193547

Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.

V Matt Laurich1, Alexander M Trbovich, Francis H O'Neill, Christopher P Houk, Patrick M Sluss, Anita H Payne, Patricia K Donahoe, Jose Teixeira.   

Abstract

Müllerian inhibiting substance (MIS) is produced by fetal Sertoli cells and causes regression of the Müllerian duct in male fetuses shortly after commitment of the bipotential embryonic gonad to testes differentiation. MIS is also produced by the Sertoli cells and granulosa cells of the adult gonads where it plays an important role in regulating steroidogenesis. We have previously shown that MIS can dramatically reduce testosterone synthesis in Leydig cells by inhibiting the expression of cytochrome P450 17alpha-hydroxylase/C(17-20) lyase (Cyp17) mRNA in vitro and in vivo. To characterize the signal transduction pathway used by MIS to control expression of endogenous Cyp17 in a mouse Leydig cell line, we demonstrate that MIS inhibits both LH- and cAMP-induced expression of Cyp17 at concentrations as low as 3.5 nM and for as long as 18 h. The induction of steroidogenic acute regulatory protein (StAR) mRNA by cAMP, however, was slightly increased by addition of MIS. Protein kinase A (PKA) inhibition with H-89 blocked Cyp17 mRNA induction, suggesting that MIS interferes with the PKA signal transduction pathway. Inhibition of Cyp17 induction was not seen with added U0126, and wortmannin inhibited the induction incompletely. In addition, phosphorylation of the cAMP responsive element binding protein (CREB) was not detected following 50 micro M cAMP exposure, a concentration sufficient for Cyp17 mRNA induction. Moreover, CREB phosphorylation, which was observed with addition of 500 micro M cAMP, was not inhibited by coincubation with MIS. Taken together, these results suggest that cAMP induces expression of Cyp17 by a PKA-mediated mechanism and that this induction, which is inhibited by MIS signal transduction, does not require CREB activity, and is distinct from that used to induce steroidogenic acute regulatory protein expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193547     DOI: 10.1210/en.2001-211352

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Identification of characteristic molecular signature of Müllerian inhibiting substance in human HPV-related cervical cancer cells.

Authors:  Seong Jin Hwang; Min Jung Suh; Joo Hee Yoon; Mee Ran Kim; Ki Sung Ryu; Suk Woo Nam; Patricia K Donahoe; David T Maclaughlin; Jang Heub Kim
Journal:  Int J Oncol       Date:  2011-05-13       Impact factor: 5.650

2.  Peritubular myoid cells participate in male mouse spermatogonial stem cell maintenance.

Authors:  Liang-Yu Chen; Paula R Brown; William B Willis; Edward M Eddy
Journal:  Endocrinology       Date:  2014-09-02       Impact factor: 4.736

3.  Fibroblast growth factor 9 (FGF9) regulation of cyclin D1 and cyclin-dependent kinase-4 in ovarian granulosa and theca cells of cattle.

Authors:  M L Totty; B C Morrell; L J Spicer
Journal:  Mol Cell Endocrinol       Date:  2016-11-03       Impact factor: 4.102

Review 4.  Müllerian inhibiting substance/anti-Müllerian hormone: a potential therapeutic agent for human ovarian and other cancers.

Authors:  David T MacLaughlin; Patricia K Donahoe
Journal:  Future Oncol       Date:  2010-03       Impact factor: 3.404

Review 5.  Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine.

Authors:  Vitaly A Kushnir; David B Seifer; David H Barad; Aritro Sen; Norbert Gleicher
Journal:  J Assist Reprod Genet       Date:  2017-06-22       Impact factor: 3.412

6.  Role of dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 in protein kinase A- and protein kinase C-mediated regulation of the steroidogenic acute regulatory protein expression in mouse Leydig tumor cells: mechanism of action.

Authors:  Pulak R Manna; Matthew T Dyson; Youngah Jo; Douglas M Stocco
Journal:  Endocrinology       Date:  2008-09-11       Impact factor: 4.736

7.  Regulation of gonadotropin gene expression by Mullerian inhibiting substance.

Authors:  Grégoy Y Bédécarrats; Francis H O'Neill; Errol R Norwitz; Ursula B Kaiser; Jose Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

8.  SMAD3 inhibits SF-1-dependent activation of the CYP17 promoter in H295R cells.

Authors:  Natalia Derebecka-Holysz; Tomasz P Lehmann; Marcin Holysz; Wieslaw H Trzeciak
Journal:  Mol Cell Biochem       Date:  2007-09-05       Impact factor: 3.396

9.  Profiling spermatogenic failure in adult testes bearing Sox9-deficient Sertoli cells identifies genes involved in feminization, inflammation and stress.

Authors:  Aurélie Lardenois; Frédéric Chalmel; Francisco Barrionuevo; Philippe Demougin; Gerd Scherer; Michael Primig
Journal:  Reprod Biol Endocrinol       Date:  2010-12-23       Impact factor: 5.211

10.  Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).

Authors:  Luis R Hoyos; Jenny A Visser; Anke McLuskey; Gregorio D Chazenbalk; Tristan R Grogan; Daniel A Dumesic
Journal:  Hum Reprod       Date:  2020-10-01       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.